Research Article

Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways

Figure 7

Effect of naringin on the PI3K/AKT pathway in the context of Aβ25–35-induced injury. (a) Immunoblots were used to assess the levels of p-AKT (Ser473, Thr308), AKT, p-GSK-3β (Ser9), GSK-3β, p-Tau (Th231, Ser396), and Tau proteins. (b) Quantitative analysis of p-AKT (Ser473)/AKT protein levels. (c) Quantitative analysis of p-AKT (Thr308)/AKT protein levels. (d) Quantitative analysis of p-GSK-3β (ser9)/GSK-3β protein levels. (e) Quantitative analysis of p-Tau (Thr231)/Tau protein levels. (f) Quantitative analysis of p-Tau (Ser396)/Tau protein levels. Data are expressed as mean ± SD (). Compared with untreated cells, **; compared with Aβ25–35-treated cells, ##; compared with the treatment group, ▲▲.
(a)
(b)
(c)
(d)
(e)
(f)